Central Drugs Standard Control Organization, Government of India has recently published their updated list of banned drugs in India. The said list of drugs are prohibited for manufacture/ import and sale in India. The Government of India has issued various…


India has been moving from offline application process to completely online applications especially in terms of applications related to licensure and product approvals of drugs, new drugs, medical devices, cosmetics, etc. We will hereby be providing you with series of…

Ethics Committee is a body responsible for ensuring that medical experimentation and human subject research are carried out in an ethical manner in accordance with national and international laws. Central Drugs Standard Control Organization, the national drug regulatory authority has…

Central Drugs Standard Control Organization (CDSCO) under the aegis of Ministry of Health and Family Welfare, Government of India has been taking many steps to control the menace of unapproved and irrational Fixed Dose Combinations (FDCs). In this process, government…
April 21, 2021 Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of India has introduced a new draft General Chapter on ‘Approach to Alternative Rapid Microbiological Method’. The proposed methods would enable faster laboratory testing of the…
Recent Post
- CDSCO Introduces Online Process for Additional Variant Applications in Cosmetics
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India